MEASURE MULTIPLE SCLEROSIS PROGRESSION WITH A CUTTING-EDGE TECHNIQUE
- Details
- Created on Saturday, 26 November 2016 11:54
Multiple sclerosis is an inflammatory disease of the nervous central system leading to a progressive destruction of the myelin sheath surrounding the axons, essential for their protection and for the transmission of the nerve impulse. Bruno Stankoff and Catherine Lubetzki’s team developed a cutting-edge imaging technique which makes possible to visualize neuron demyelination and remyelination and to quantify their degeneration. These results, published in Annals of Neurology, open the way to better treatment for patients and to the evaluation of novel remyelination therapies.
Thesis defense : “ Consequences of APP soluble forms overexpression in memory processes and its therapeutical application to Alzheimer’s disease.”
- Details
- Created on Thursday, 15 September 2016 08:50
Wednesday September the 21st, World Alzheimer's Day, will be held at CEA of Fontenay aux roses a thesis defense by Romain Fol on this topic. The discussion will precisely focus on the “ Consequences of APP soluble forms overexpression in memory processes and its therapeutical application to Alzheimer’s disease.”
THE SILENT STAGE OF ALZHEIMER’S DISEASE
- Details
- Created on Monday, 08 August 2016 06:46
http://icm-institute.org/en/actualite/the-silent-stage-of-alzheimers-disease/
A major international conceptual diagnostic criteria and conceptual breakthrough program has been successfully launched and published, led by the UPMC and ICM researchers Professor Bruno Dubois and Professor Harald Hampel (AXA – UPMC Chair) who coordinated a distinguished group of major international key opinion leaders, based on the dynamic conceptual evolution of the paradigm of preclinical Alzheimer’s disease (AD), in the March Issue of the leading international Alzheimer Journal Alzheimer’s & Dementia, The Journal of the Alzheimer’s Association.
Multiple Sclerosis: an essay raised hopes for aggressive forms
- Details
- Created on Thursday, 23 June 2016 14:00
Treatment successfully interrupted the occurrence of relapses in patients with an aggressive form of multiple sclerosis and to prevent the emergence of new brain lesions on MRI.
